GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | Nfe2l2 | multiple interactions | EXP | | 6480464 | CTD | Cilostazol inhibits the reaction [Cyclophosphamide results in decreased expression of NFE2L2 mRNA]; Cilostazol inhibits the reaction [Thioacetamide results in decreased expression of NFE2L2 protein]; Verapamil promotes the reaction [Cilostazol inhibits the reaction [Thioacetamide results in decreased expression of NFE2L2 protein]] | PMID:30295103 PMID:32456565 | Nfe2l2 | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | CTD | cilostazol results in increased expression of NFE2L2 protein | PMID:20131233 | Nfe2l2 | increases response to substance | ISO | NFE2L2 (Homo sapiens) | 6480464 | CTD | NFE2L2 results in increased susceptibility to cilostazol | PMID:20131233 | Nfe2l2 | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | CTD | NFE2L2 mutant form inhibits the reaction [cilostazol results in increased expression of HMOX1 protein] | PMID:20131233 | |
Go Back to source page | Continue to Ontology report |